Illumina said today it agreed to acquire the majority stake it does not already own in cancer blood test developer GRAIL for $8 billion in cash and stock, confirming nearly a week of speculation that ...

Test-driven development may be more talked about than practiced Your email has been sent Everyone is talking about test-driven development. Is anyone actually doing it? TDD has been embraced by the ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline. The conglomerate’s investment—which collectively ...

Arlington, VA – The Integrated Personnel and Pay System – Army’s (IPPS-A) Release 3 team continues to meet program timelines with the formal kickoff for Developer Integration Test (DIT) held November ...

You can even use it to test their UI development skills if you ask them to create a front end. Test projects for data scientists Preferences application: Ask data scientist and data science developer ...

After collecting an FDA clearance last year for its smartphone-based home kidney test, Healthy.io is letting it be known that it has the cash to help back it up. The company disclosed a previously ...

The new tools will help mods and let people make posts with live scoreboards, but they’ll only be available to a small number of communities to start. The new tools will help mods and let people make ...

The Federal Trade Commission (FTC) on Monday ordered life sciences company Illumina to unwind its $7.1 billion acquisition of cancer detection test developer Grail Inc., citing antitrust concerns. The ...